| Date Filed | Type | Description |
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 05/12/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/03/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/02/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 12/28/2022 |
RW
| Form RW - Registration Withdrawal Request: |
| 11/01/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 08/04/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/12/2022 |
8-K
| Quarterly results |
| 05/10/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/05/2022 |
8-K
| Quarterly results |
| 02/22/2022 |
8-K
| Quarterly results |
| 02/03/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 01/25/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 11/02/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 08/03/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 06/25/2021 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
| 06/15/2021 |
8-K
| Quarterly results |
| 06/15/2021 |
PRE 14C
| Form PRE 14C - Other preliminary information statements: |
| 05/10/2021 |
8-K
| Quarterly results |
| 05/05/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 03/09/2021 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/02/2021 |
10-KT
| Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]: |
| 01/21/2021 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 12/30/2020 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year |
| 12/29/2020 |
10-Q
| Quarterly Report for the period ended November 30, 2020 |
| 12/10/2020 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 12/08/2020 |
SC 13D
| Case Western Reserve University reports a 50% stake in Mosaic ImmunoEngineering Inc. |
| 12/01/2020 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 11/19/2020 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/02/2020 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
| 10/23/2020 |
PRE 14C
| Form PRE 14C - Other preliminary information statements: |
| 10/15/2020 |
10-Q
| Quarterly Report for the period ended August 31, 2020 |
| 10/14/2020 |
8-K/A
| Quarterly results |
| 08/25/2020 |
8-K
| Quarterly results |
|